Remed Co.,Ltd. (KOSDAQ:302550)
South Korea · Delayed Price · Currency is KRW 3,165.00
-15.00 (-0.47%)
At close: Apr 20, 2026
Remed Revenue
In the year 2025, Remed had annual revenue of 24.50B KRW, down -4.11%. Remed had revenue of 6.70B in the quarter ending December 31, 2025, with 3.86% growth.
Revenue
24.50B
Revenue Growth
-4.11%
P/S Ratio
3.99
Revenue / Employee
266.36M
Employees
92
Market Cap
97.82B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 24.50B | -1.05B | -4.11% |
| Dec 31, 2024 | 25.55B | 7.02B | 37.86% |
| Dec 31, 2023 | 18.54B | -2.83B | -13.23% |
| Dec 31, 2022 | 21.36B | 1.17B | 5.79% |
| Dec 31, 2021 | 20.20B | 3.56B | 21.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Genoray | 108.04B |
| DRGEM | 102.75B |
| JPI Healthcare | 48.47B |
| L&K Biomed | 38.92B |
| Hironic | 32.09B |
| SELVAS Healthcare | 30.82B |
| Neofect | 16.05B |
| MEKICS CO., | 11.29B |